Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fernando Duret"'
Autor:
Carlos Bantar, Francisco Salamone, Carina Arango, Diego Franco, María Alicia Coassolo, Alejandro Fiorillo, Maria E. Oliva, Claudia Heft, Fernando Duret, Hernán Gomez, Marcelo Krayeski, Eduardo Vesco
Publikováno v:
Antimicrobial Agents and Chemotherapy. 48:392-395
We have previously observed a significant reduction of ceftriaxone resistance in Proteus mirabilis associated with an increase in the use of cefepime, along with a decrease in the consumption of broad-spectrum cephalosporins (CEP). However, we did no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c64896475143af2dc849b47000dc65
https://doi.org/10.1128/aac.48.2.392-395.2004
https://doi.org/10.1128/aac.48.2.392-395.2004
Publikováno v:
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 24(6)
Tigecycline is a new class of antibiotics active against emerging nosocomial pathogens as methicillin-resistant Staphylococcus aureus, extended spectrum (3-lactamases-producing enterobacteria and multidrug-resistant Acinetobacter sp. It was approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d93e0aa798fb441a3421b4c285823d7
https://pubmed.ncbi.nlm.nih.gov/18180827
https://pubmed.ncbi.nlm.nih.gov/18180827
Publikováno v:
Revista chilena de infectología v.24 n.6 2007
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Tigeciclina es una nueva clase de antimicrobiano activo contra patogenos nosocomiales emergentes como Staphylococcus aureus resistente a meticilina, enterobacterias productoras de (3-lactamasas de espectro extendido y Acinetobacter sp multi-resistent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2872636cfd1626cc0cfc60dcf4e190
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182007000600012
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182007000600012
Publikováno v:
Journal of chemotherapy (Florence, Italy). 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9fd3f19364b4d729bef45f0b1c55596
https://pubmed.ncbi.nlm.nih.gov/17855193
https://pubmed.ncbi.nlm.nih.gov/17855193
Publikováno v:
Journal of the American Geriatrics Society. 55:312-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b241eb5d7ec18e46fa97e364ee411a96
https://doi.org/10.1111/j.1532-5415.2007.01056.x
https://doi.org/10.1111/j.1532-5415.2007.01056.x